Table 1:
Characteristics of patient sample (N=6,506)
| N (%) | |
|---|---|
| Demographics | |
| Age (years)* | |
| Mean | 53.8 (13.9) |
| Gender | |
| Female | 3,791 (58.3%) |
| Male | 2,715 (41.7%) |
| Race | |
| Black | 2,657 (40.8%) |
| Non-Black | 3,849 (59.2%) |
| Liver Tests | |
| LFT Panel Results** | 73,067 |
| Mean per patient (SD) | 11.2 (16.0) |
| Median per patient (IQR) | 6 (3–13) |
| LFT Panels with Abnormal | 27,019 |
| Mean per patient (SD) | 4.5 (8.2) |
| Median per patient (IQR) | 2 (1–4) |
| NAFLD Diagnoses † | 313 (4.8%) |
| MetS Components | |
| BP > 130/85 | 5,820 (89.5%) |
| A1c > 6.5% | 1,693 (26.0%) |
| Low HDL | 4,504 (69.2%) |
| Triglyceride > 150 | 2,729 (42.0%) |
| BMI > 30 | 3,025 (46.5%) |
| # of MetS Components | |
| 0 | 159 (2.4%) |
| 1 | 1,072 (16.5%) |
| 2 | 1,654 (25.4%) |
| 3 | 1,719 (26.4%) |
| 4 | 1,276 (19.6%) |
| 5 | 626 (9.6%) |
| Comorbidities‡ | |
| Smoking history | 2,813 (43.2%) |
| Drug Use | 530 (8.2%) |
*
Age is calculated by the patient’s last data point in the study period
**
total number of liver function test panel results, not the individual components (transaminases)
***
Pattern assigned on the first liver test abnormality.
†
NAFLD and NASH diagnosis codes (571.8, K75.81, or K76.0.
‡
Comorbidities according to ICD-9/10 Elixhauser coding algorithm (38). LFT=liver function test; NAFLD=nonalcoholic fatty liver disease; MetS=metabolic syndrome; BP=blood pressure; HDL=high-density lipoprotein; BMI=body mass index (kg/m2)